(Q30997802)

28 June 2017

Alterations of serum protein N-glycosylation in two mouse models of chronic liver disease are hepatocyte and not B cell driven (English)

1 reference

28 June 2017

1 reference

chronic liver disease

0 references

Nico Callewaert

6

0 references

Hans Van Vlierberghe

7

object named as

Hans Van Vlierberghe

1 reference

Christophe Van Steenkiste

28 June 2017

2

object named as

Christophe Van Steenkiste

1 reference

28 June 2017

Bram Blomme

1

1 reference

28 June 2017

Paola Grassi

3

1 reference

28 June 2017

Stuart M Haslam

4

1 reference

28 June 2017

Anne Dell

5

1 reference

28 June 2017

3 February 2011

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

28 June 2017

1 reference

28 June 2017

300

1 reference

28 June 2017

G833-42

1 reference

28 June 2017

5

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

28 June 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Nucleotide sugar transporters: biological and functional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Optimization of the dose and route of injection, and characterisation of the time course of carbon tetrachloride-induced hepatotoxicity in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Glycomic profiling of cells and tissues by mass spectrometry: fingerprinting and sequencing methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Antibody therapeutics: isotype and glycoform selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Modifications of human total serum N-glycome during liver fibrosis-cirrhosis, is it all about immunoglobulins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Functionally important glycosyltransferase gain and loss during catarrhine primate emergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Glycome mapping on DNA sequencing equipment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Fucosylated glycoproteins as markers of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Attenuated liver fibrosis in the absence of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

UDP-GlcNAc concentration is an important factor in the biosynthesis of beta1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00228.2010

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00228.2010

1 reference

28 June 2017

1 reference